Showing results (41-50 of 757) with videos related to
Sort By:
Pageof 76
International Journal of Obstetric Anesthesia|March 30, 2005
Anaesthetic considerations in a parturient with critical coronary artery disease and a drug-eluting stent presenting for caesarean sectionJ A Cuthill, S Young, I A Greer, et al.Journal of the Society for Gynecologic Investigation|January 1, 1997
Treatment of endothelial cells with serum from women with preeclampsia: effect on neutrophil adhesionC J Clark, F Boswell, I A Greer, et al.British Journal of Obstetrics and Gynaecology|August 6, 1998
Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparinJ L Gibson, K Ekevall, I Walker, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 1, 1988
Effect of maternal ketorolac administration of platelet function in the newbornI A Greer, J Johnston, I Tulloch, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 1, 1990
Umbilical artery Doppler flow velocity waveforms and maternal prostaglandin E2 and F2 alpha metabolite concentrations during cervical ripening with prostaglandin E2F M Fairlie, G D Lang, I A Greer, et al.American Journal of Obstetrics and Gynecology|April 17, 2001
Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamicsA E Nicoll, F Mackenzie, I A Greer, et al.Obstetrics and Gynecology|July 1, 1991
Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertensionI A Greer, J Dawes, T A Johnston, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1995
Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancy: treatment with low-molecular-weight heparinN S Macklon, I A Greer, A W Reid, et al.Clinical Endocrinology|November 1, 1994
Corticotrophin-releasing factor immunostaining is present in placenta and fetal membranes from the first trimester onwards and is not affected by labour or administration of mifepristoneE S Cooper, A N Brooks, M R Miller, et al.Placenta|May 1, 1997
Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at deliveryF Lyall, A Young, F Boswell, et al.Pageof 76